Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Conditions
Gynecologic Cancer · Carcinoma · Uterine Cancer · Endometrial Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
O'Neal Comprehensive Cancer Center at UAB, Birmingham, Alabama, United States
Contact: Principal Investigator (Michael Toboni, MD)Rebecca Arend, MD (Sub-investigator)